Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2792 of 5804
-
Real-World check: newer PNH drug holds up in routine care
Disease control CompletedThis study will collect clinical response data on participants who were already treated with eculizumab for at least 26 weeks and who started ravulizumab treatment as a specific therapeutic strategy as per ordinary clinical practice.
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New study pits two prostate procedures Head-to-Head for big glands
Symptom relief OngoingThe purpose of this research study is to evaluate prostate artery embolization (PAE) compared to Holmium laser enucleation of prostate (HoLEP) in improving a patient's overall prostate related symptoms.
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Brain zaps for the blues: new study tests Quick-Pulse therapy
Symptom relief CompletedThe investigators will administer theta burst stimulation (TBS) in efforts to observe a decrease in severity of reported depression symptoms. A subset of participants will receive positive affect training during this intervention.
Phase: NA • Sponsor: Erika Forbes • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New hope for tough blood cancers: experimental drug HRS-3738 enters human testing
Disease control OngoingThis study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-3738 in patients with recurrent and refractory Non-Hodgkin's lymphoma and multiple myeloma.
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a custom vaccine retrain the immune system in type 1 diabetes?
Disease control OngoingThis phase I trial investigates the side effects of PIpepTolDC vaccine in treating patients with type 1 diabetes who use insulin and don't have any other diabetes-related health complications. Type 1 diabetes is an autoimmune disease. This means that the immune system, which usua…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New needle treatment smooths cellulite dimples
Symptom relief CompletedThe aim of the study is to evaluate the safety and efficacy of Morpheus 8 Body 40-pin tip up to 7mm depth Applicator for subdermal treatment of cellulite appearance, skin laxity, and subcutaneous fat deposits.
Phase: NA • Sponsor: InMode MD Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
App and website aim to ease perinatal depression care
Symptom relief CompletedInvestigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 26, 2026 16:36 UTC
-
New pilot aims to speed up autism diagnosis for georgia toddlers
Knowledge-focused Recruiting nowBabies Can't Wait (BCW) in Georgia will be referring families with children seeking an autism spectrum disorder (autism) diagnosis at the Emory Autism Center's (EAC) Child Screening and Assessment Clinic.The objective of this study is to develop, pilot, and evaluate a diagnostic …
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can a children's chemo recipe help adults with leukemia? early trial adds venetoclax to the mix.
Disease control OngoingThe researchers are doing this study to find out whether combining venetoclax with several different standard chemotherapy drugs used to treat acute lymphoblastic leukemia (ALL) in children is safe and effective in adults with newly diagnosed ALL. Participants in this study will …
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a tailored drug dose cut transfusions for kids with sickle cell?
Disease control OngoingADAPT is a prospective cohort study at Jinja Regional Referral Hospital (JRRH) primarily to assess the effect of hydroxyurea on blood transfusion utilization and secondarily to determine the feasibility of PK-guided hydroxyurea dosing.
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for kids with kidney disease: drug targets dangerous phosphorus levels
Disease control TerminatedThis study will be conducted to assess the safety and tolerability of ferric citrate in pediatric participants with hyperphosphatemia related to chronic kidney disease (CKD).
Phase: PHASE3 • Sponsor: Keryx Biopharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Hormone hacks: could your period make OCD therapy work better?
Knowledge-focused Recruiting nowStudies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Cash for clean tests: can rewards boost opioid recovery?
Disease control OngoingContingency management (CM) is a behavioral intervention that involves incentivizing participants for target behaviors in a clinical setting. When applied to the treatment of substance use disorders, it has demonstrated efficacy in reducing the number of urine toxicology screens …
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 26, 2026 14:46 UTC
-
Brain scans reveal why menopause makes some women snappy
Knowledge-focused CompletedWomen in the menopause transition (perimenopause) experience substantial day-to-day variability in estradiol and have a 2-4-fold increase in major depression risk. About 40% of perimenopausal women are susceptible to the emergence of affective symptoms tied to changes in estradio…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can cutting extra pills help older cancer patients get better chemo?
Symptom relief CompletedThis is a single-site cluster-randomized trial to assess efficacy and implementation outcomes of deprescribing interventions in 72 older adults with polypharmacy (PP) and curable cancers initiating chemotherapy. Oncologists (as the cluster) will enroll 6 patients each and will be…
Phase: PHASE1, PHASE2 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Vibrating muscles may ease Post-Stroke spasticity, early trial hopes
Symptom relief Recruiting nowSeveral studies have recently tested the use of muscle vibration for the rehabilitation of patients after a stroke. When applied in a repeated and focused manner, this vibration appears to promote the recovery of functional capacities through the mechanisms of neuromuscular plast…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New imaging clues could help tailor breast cancer care
Knowledge-focused Recruiting nowObjectives: Our study is conducted to use the pre-treatment Fluorocholine (FCH) Positron emission tomography/magnetic resonance (PET/MR) imaging in breast cancer patients, to investigate whether the conventional PET/MR imaging markers (maximum standardized uptake value \[SUVmax\…
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New Immune-Targeting drug tested for stubborn cancers
Disease control CompletedThis is a Phase 1, open-label, 2-part, multi-center study evaluating the safety, tolerability, PK, pharmacodynamics (PD), immunogenicity, and antitumor activity of CUE-102 intravenous (IV) monotherapy in HLA-A\*0201 positive patients with WT1 positive recurrent/metastatic solid t…
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Heartburn drug could ease painful sun sensitivity
Disease control CompletedErythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) result from genetic defects of heme biosynthesis that cause life-long, painful cutaneous sensitivity to light. The objective of this study is to determine the efficacy and safety of oral cimetidine administrati…
Phase: PHASE2 • Sponsor: Amy K. Dickey, M.D. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Money and parenting skills may curb child behavior problems in uganda
Disease control OngoingThe study will examine the mechanisms by which Economic Empowerment (EE) and Family Strengthening (FS) interventions targeting social, familial and context-specific drivers affect childhood behavioral health (CBH). The study will randomly assign 900 children in mid-upper primary …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC